Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Surveillance

Surveillance: Post Drug-Approval Activities

                        Report a Product Quality Issue


                        Office of Prescription Drug Promotion
          Prescription Drug Advertising and Promotional Labeling
          Questions and Answers on FDA's Adverse Event Reporting System (FAERS) Home
          Drugs
          Guidance, Compliance, & Regulatory Information
          Surveillance: Post Drug-Approval Activities
          Report a Product Quality IssueSurveillance: Post Drug-Approval Activities Report a Product Quality Issue
  
  	
    Share
    Post
    Linkedin

    Email
    PrintField Alert Reports—Identify quality defects in distributed drug products that may present a potential safety threatCDER—Biological Product Deviation ReportsRelated Resoures for Reporting Adverse Events to FDAFor industry: FDA Adverse Events Reporting System (FAERS) Electronic SubmissionsFor the general public: MedWatch

                                                                                  Content current as of:
      11/17/2016Surveillance: Post Drug-Approval Activities

          
                        Report a Product Quality Issue


                        Office of Prescription Drug Promotion
          Prescription Drug Advertising and Promotional Labeling
          Questions and Answers on FDA's Adverse Event Reporting System (FAERS)
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop